Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupture in a 9-year-old child.
OBJECTIVE
To describe a case in which a 9-year-old boy who sustained a traumatic choroidal rupture, and later developed choroidal neovascularization (CNV), was successfully treated with intravitreal bevacizumab.


METHODS
Comprehensive ophthalmic evaluation, including fundus photography, fluorescein angiography, optical coherence tomography, and B-scan ultrasonography, was done to follow the patient's course and response to treatment over a 2-month period.


RESULTS
Preinjection visual acuity was 20/200. Fluorescein angiography showed significant leakage, and optical coherence tomography revealed macular edema. One month after injection, visual acuity was 20/20, with resolution of leakage and edema by fluorescein angiography and optical coherence tomography, respectively.


CONCLUSIONS
There was dramatic improvement in visual acuity from a single intravitreal injection of bevacizumab. This case shows promise for future applications of bevacizumab as treatment of CNV arising from a traumatic choroidal rupture.
From the Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan.
Arun
A
Prasad
Chirag C
CC
Patel
James E
JE
Puklin